Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter.
about
Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's diseaseDeletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability.Exaggerated emotional behavior in mice heterozygous null for the sodium channel Scn8a (Nav1.6).NR2B-deficient mice are more sensitive to the locomotor stimulant and depressant effects of ethanolEarly-life forebrain glucocorticoid receptor overexpression increases anxiety behavior and cocaine sensitization.Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome.Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator.L-type voltage-gated calcium channels in conditioned fear: a genetic and pharmacological analysis.Deletion of fibroblast growth factor 22 (FGF22) causes a depression-like phenotype in adult mice.On the occurrence of hypomyelination in a transgenic mouse model: a consequence of the myelin basic protein promoter?Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.Postnatal separation prevents the development of prenatal stress-induced anxiety in association with changes in oestrogen receptor and oxytocin immunoreactivity in female mandarin vole (Microtus mandarinus) offspring.The L-type voltage-gated calcium channel CaV1.2 mediates fear extinction and modulates synaptic tone in the lateral amygdala.Presymptomatic change in microRNAs modulates Tau pathology.
P2860
Q27313627-5E728E72-6B10-4C9C-95A9-9F0FA27778A6Q30474898-4BC79C84-D039-4FBB-AFF7-F2D09CAEC889Q33888893-2B4755C8-FD98-4D1A-A5D9-8CAFF4B36939Q34162623-90ED4618-B7D8-48F8-BB28-3C1CC78BC20CQ35633204-9467AD49-10BC-4122-B2CE-FBA1EA5DF443Q35921272-066C3EB5-C588-4A97-BCF4-D7EB26AFFE49Q36202682-40B1A0F9-D0E2-49AC-90F0-B2397D40EDF0Q36625554-8BC515BC-6572-4E1B-8081-7B18CED76EADQ36858552-96CC57DD-EC82-4F55-BE7B-0E922A9D7F57Q37174777-4E79DF32-DC04-4F50-B3AD-DA87D33F7EE7Q37497222-2EDCDFA8-0E43-433D-9DC8-68ECA7B175C2Q41695282-F07C552C-EED8-4F78-9A35-9C257F429FADQ47283638-CEB4B2BA-A0F0-4581-8556-64594316C8AEQ47781311-0A9A95DD-8E50-4B09-863B-A3FC2994FCBAQ55307073-2F0B77C6-6053-4B90-8F9B-01F50F517DCA
P2860
Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Decreased locomotor activity i ...... of the CaMKII alpha promoter.
@en
Decreased locomotor activity i ...... of the CaMKII alpha promoter.
@nl
type
label
Decreased locomotor activity i ...... of the CaMKII alpha promoter.
@en
Decreased locomotor activity i ...... of the CaMKII alpha promoter.
@nl
prefLabel
Decreased locomotor activity i ...... of the CaMKII alpha promoter.
@en
Decreased locomotor activity i ...... of the CaMKII alpha promoter.
@nl
P2093
P2860
P1476
Decreased locomotor activity i ...... l of the CaMKII alpha promoter
@en
P2093
A F Seasholtz
G G Murphy
G L Schafer
J L Lowing
J S Schneider
P2860
P304
P356
10.1111/J.1601-183X.2007.00339.X
P407
P577
2007-07-19T00:00:00Z